VT3989 3 month DRGs panelled secondary only PLP-GFP CTGF.tif

syn24987632

Created By Liyam Laraba liyamlaraba

studyId: syn22268652
studyName: The use of novel YAP/TEAD Hippo pathway inhibitors to target Merlin (NF2) null tumors
initiative: Young Investigator Award
fundingAgency: CTF

VT3989 3 month DRGs panelled secondary only PLP-GFP CTGF.tif page is loading…